Ekso Bionics Holdings Q1 2024 GAAP EPS $(0.20) Misses $(0.16) Estimate, Sales $3.756M Miss $4.993M Estimate
Ekso Bionics Holdings Q1 2024 GAAP EPS $(0.20) Misses $(0.16) Estimate, Sales $3.756M Miss $4.993M Estimate
Ekso Bionics Holdings 2024年第一季度GAAP每股收益美元（0.20）未达到预期（0.16）美元，销售额375.6万美元未达到49.93万美元的预期
Ekso Bionics Holdings (NASDAQ:EKSO) reported quarterly losses of $(0.20) per share which missed the analyst consensus estimate of $(0.16) by 25 percent. This is a 39.39 percent increase over losses of $(0.33) per share from the same period last year. The company reported quarterly sales of $3.756 million which missed the analyst consensus estimate of $4.993 million by 24.77 percent. This is a 8.88 percent decrease over sales of $4.122 million the same period last year.
Ekso Bionics Holdings（纳斯达克股票代码：EKSO）公布的季度亏损为每股0.20美元，比分析师普遍预期的0.16美元（0.16美元）低25％。与去年同期每股亏损0.33美元（0.33美元）相比，增长了39.39％。该公司公布的季度销售额为375.6万美元，比分析师普遍预期的499.3万美元低24.77％。这比去年同期的412.2万美元的销售额下降了8.88％。